Maze Therapeutics MAZE
NASDAQ MAZE
$27.30 +0.28 (+1.03%)
As of: Sep 30, 2026 · 1:38 PM EDT

Maze Therapeutics, Inc. (MAZE) Total Non-Current Liabilities (2024 - 2026)

Updated

Maze Therapeutics (MAZE) recorded Total Non-Current Liabilities of $77.62 million in Q1 2026, up 95.2% from $39.77 million a year earlier and up 89.0% from the prior quarter.

Analysis

Maze Therapeutics, Inc. (MAZE) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Maze Therapeutics reported Total Non-Current Liabilities of $41.07 million, down 92.5% from FY2024.

  • Across earlier years, Total Non-Current Liabilities came in at $550.76 million in FY2024.
  • The Q1 2026 figure is the highest quarterly Total Non-Current Liabilities since Q4 2024.
  • Per Business Quant, the preceding three quarters came in at $41.07 million (Q4 2025), $41.53 million (Q3 2025) and $40.19 million (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 77.62 Mn
Dec 31, 2025 41.07 Mn
Sep 30, 2025 41.53 Mn
Jun 30, 2025 40.19 Mn
Mar 31, 2025 39.77 Mn
Dec 31, 2024 550.76 Mn
API Access

Maze Therapeutics, Inc. Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MAZE&period=max&api_key=YOUR_API_KEY